交易中 09-20 12:36:54 美东时间
+0.005
+0.18%
Verastem, Inc. : H.c. Wainwright Cuts Target Price to $7 From $17.5
08-12 18:04
RBC Capital analyst Gregory Renza maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $16 to $13.
08-10 03:52
Verastem Inc : RBC Cuts Target Price to $13 From $16
08-09 13:12
Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.95) by 35.79 percent. This is a 42.45 percent increase over losses of $(1.06) per share from the same
08-09 05:18
Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Def...
07-30 04:01
Verastem Inc - Expect to Report Updated Data From Ongoing Ramp 205 Trial in Fir...
07-30 04:01
Verastem Inc - to Report Updated Ramp 205 Data in Q1 2025
07-30 04:01